Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|August 26, 1998
Methylguazone, vindesine and cisplatin for the treatment of patients with relapsed or refractory malignant lymphoma: an Eastern Cooperative Oncology Group Study (PA482)P H Wiernik, V Phillips, F J Camacho, et al.
Medical and Pediatric Oncology|January 1, 1979
Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: response to chemotherapy in two casesL I Gordon, W Hrushesky, M M Oken, et al.
The New England Journal of Medicine|January 8, 1987
Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancerJ J Yunis, G Frizzera, M M Oken, et al.
Cancer|April 15, 1994
Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myelomaR E Lenhard, L A Kalish, M M Oken, et al.
Cancer Genetics and Cytogenetics|September 1, 1984
Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphomaJ J Yunis, M M Oken, A Theologides, et al.
Cancer|May 15, 1993
Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group studyW R Friedenberg, J Anderson, B C Wolf, et al.
Cancer Treatment Reports|January 1, 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomasM J O'Connell, C B Begg, M N Silverstein, et al.
Leukemia & Lymphoma|July 28, 2016
Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group StudyM M Oken, R A Kyle, N E Kay, et al.
British Journal of Haematology|April 1, 1992
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemiaT M Habermann, J W Andersen, P A Cassileth, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group studyJ M Bennett, G H Lymann, P A Cassileth, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|August 26, 1998
Methylguazone, vindesine and cisplatin for the treatment of patients with relapsed or refractory malignant lymphoma: an Eastern Cooperative Oncology Group Study (PA482)P H Wiernik, V Phillips, F J Camacho, et al.
Medical and Pediatric Oncology|January 1, 1979
Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: response to chemotherapy in two casesL I Gordon, W Hrushesky, M M Oken, et al.
The New England Journal of Medicine|January 8, 1987
Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancerJ J Yunis, G Frizzera, M M Oken, et al.
Cancer|April 15, 1994
Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myelomaR E Lenhard, L A Kalish, M M Oken, et al.
Cancer Genetics and Cytogenetics|September 1, 1984
Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphomaJ J Yunis, M M Oken, A Theologides, et al.
Cancer|May 15, 1993
Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group studyW R Friedenberg, J Anderson, B C Wolf, et al.
Cancer Treatment Reports|January 1, 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomasM J O'Connell, C B Begg, M N Silverstein, et al.
Leukemia & Lymphoma|July 28, 2016
Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group StudyM M Oken, R A Kyle, N E Kay, et al.
British Journal of Haematology|April 1, 1992
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemiaT M Habermann, J W Andersen, P A Cassileth, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group studyJ M Bennett, G H Lymann, P A Cassileth, et al.
Pageof 15